Buy Semaglutide Online
Buy Semaglutide Online
- Controls hunger
- Reduces food cravings
- Increases satiety after eating
- Increases weight loss
- Lowers blood sugar
- Increases insulin sensitivity
- Decreases type 2 diabetes risk
- Lowers blood pressure
- Improves cholesterol levels
- Reduces triglycerides
Dosage varies per month (0.25mg – 2.5mg)
- Stomach pain
- Upset stomach
- Feeling bloated
- Injection site reactions
Discuss your treatment plan with one of our licensed practitioners.
All medications and supplies included, no hidden fees.
Our well-trained medical staff are ready to answer your questions.
Benefits of Semaglutide
Semaglutide is a medication that induces weight loss by acting on receptors that control food intake, cravings, metabolism, and energy use throughout your body. Losing excess weight can provide many health benefits by improving cardiovascular and metabolic health, increasing your health span, and restoring hormones, such as testosterone, to their baseline levels.
- Reduced pain
- Decreased blood pressure
- Decreased risk for cardiovascular disease
- Better lung function
- Reduced risk for stroke or heart disease
- Lower triglycerides
- Improved mobility
- Less joint damage
- Enhanced libido
- Higher self-esteem
- Better sleep
Do I Need Semaglutide?
- Food cravings
- Unhealthy body weight
- Excessive hunger
- Increased blood sugar
Semaglutide helps people with obesity shed excess pounds. Semaglutide acts as an incretin mimetic, which means that it helps the pancreas release insulin when blood sugars are too high. It also slows stomach emptying and intestinal motility, so you feel full longer. In addition, semaglutide helps people resist food cravings.
In clinical trials, the group that took semaglutide consistently lost more weight than the group taking a placebo. The average weight loss was 35 pounds, or 15% of their body weight. Overall, the medication was well-tolerated and effective.
Semaglutide is not right for everyone. People with the following conditions should not take semaglutide:
- Medullary thyroid carcinoma (personal or family history)
- Multiple endocrine neoplasia syndrome type 2
- Taking another GLP-1 receptor agonist
- History of diabetic ketoacidosis
- History of pancreatitis
- Known hypersensitivity to semaglutide or any of the injection components
Tell your doctor if you have had:
- A stomach or intestinal disorder
- Kidney disease
- Eye problems caused by diabetes
Semaglutide has side effects, as do all medications. It is generally well-tolerated. The side effects are transient and mild in severity.
The most common side effects reported in clinical trials are:
- Stomach pain
- Upset stomach
- Feeling bloated
- Stomach flu
More serious side effects include:
- Inflammation of the pancreas
- Potential increased risk of thyroid C-cell tumors
- Gallbladder problems
- Low blood sugar
- Kidney problems
- Serious allergic reactions
- Increased heart rate
- Depression or thoughts of suicide
Semaglutide has two versions to treat type 2 diabetes: an FDA-approved injectable (brand name Ozempic) and an oral pill (brand name Rezempic).
Wegovy is an injectable form of semaglutide used to treat overweight or obesity. Researchers are testing a pill form of semaglutide to treat obesity.
Yes, a prescription is needed to get semaglutide. Generic semaglutide and brand names Ozempic, Rybelsus, and Wegovy all require prescriptions. Semaglutide is not right for everyone. A medical professional will evaluate your past medical history and risk factors for side effects before prescribing semaglutide.
Participants in clinical trials had stalled weight loss around week 60 and rebound weight gain after they stopped semaglutide.
Therefore, it is important to make semaglutide part of a weight maintenance plan, along with a low-calorie diet and a solid exercise plan. Develop good diet and exercise habits while taking semaglutide to make it easier to keep the weight off after you stop taking it.
Your doctor will discuss with you how long to take semaglutide and whether you will need to gradually wean off it.
Yes, prescription semaglutide is only one part of an effective weight management plan. Consuming a healthy diet and getting regular exercise are also very important for both weight loss and overall health.
No, Invigor Medical employs doctors licensed in all 50 states, and a medical consultation is included with each medical service. Each patient will receive a valid prescription, which is sent to the pharmacy to be filled.
Once you have enrolled for medical services with Invigor Medical, it usually takes 7-14 business days before items arrive at your home. This process includes an online medical consultation, prescription approval, the medication getting filled at the pharmacy, and the medication being sent to your home.
Semaglutide is an FDA-approved medication for weight loss that works just like your body’s own GLP-1 hormone. After a meal, your intestines secrete GLP-1 hormone. This hormone helps lower your blood sugar, makes you feel full longer, and reduces your cravings.
Because semaglutide increases insulin release and lowers your blood sugar, it has been used for more than 15 years to treat type 2 diabetes.
In higher doses, semaglutide also acts in the brain, reducing hunger and suppressing cravings. In clinical trials, participants with obesity lost an amazing 15% of their body weight, and nearly a third lost 20%. While weight loss is important, semaglutide also improves other health markers, lowering the risk of heart disease, stroke, diabetes, and cancer.
Semaglutide should be used as part of a comprehensive weight-loss plan. When people stop taking semaglutide, they tend to regain their lost weight unless they have made a low-calorie diet and exercise a part of their daily routine.
Gastrointestinal side effects like nausea, vomiting, diarrhea, and constipation are the most common side effects when using semaglutide. These symptoms are usually transient and are typically mild in severity.
What is Semaglutide?
Semaglutide is an FDA-approved Medication for Weight Loss
Semaglutide, also marketed under the brand names Ozempic, Rybelsus, and Wegovy, is an FDA-approved injectable for weight loss that mimics the actions of GLP-1, a hormone that targets specific areas of the brain known to control hunger.
The ideal candidates for semaglutide are people with a BMI of 30 or greater or a BMI of 27 or greater and a medical condition made worse by obesity. Semaglutide is used in conjunction with a reduced-calorie diet and exercise.
People who take semaglutide report altered food preferences, reduced cravings, less hunger, and increased satisfaction after eating, resulting in lower calorie consumption. Many people who take semaglutide say that they no longer think about food all day. The terrible food cravings that permeate their days are gone.
In clinical trials, users lost an average of 35 pounds. This is 15% or more of their body weight. Semaglutide is expected to work best for people who have trouble controlling their appetite and like to snack.
Obesity is Associated with B12 Deficiency
Semaglutide from Invigor Medical is compounded with vitamin B12. Low vitamin B12 levels are linked to an increased risk of obesity, insulin resistance, abnormal blood cholesterol and triglycerides, and heart disease.
B12 is involved in regulating DNA and how it codes for proteins. Research suggests that vitamin B12 may be involved in regulating how fats are deposited in your body and how they are used for energy.
The Science of Semaglutide
Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist that works like the GLP-1 hormone your body makes naturally. Semaglutide is structurally very similar to GLP-1 but is at a much higher dose than what your body normally produces.
GLP-1 binds to receptors in your pancreas, stomach lining, and brain, among other places.
Your pancreas releases insulin. This hormone ushers glucose (sugar) from your bloodstream into your body cells. When your blood sugar is high, it can damage the inner lining of your blood vessels. This increases your risk for heart disease, blood vessel disease, and stroke.
Once inside your body cells, glucose is used for cellular energy. Any excess glucose can be converted to fat and stored as fat tissue.
Glucagon is also released from your pancreas, and it raises your blood sugar. Semaglutide lowers your blood sugar by increasing insulin release and decreasing glucagon release. By lowering your blood sugar, semaglutide lowers your risk for type 2 diabetes and cardiovascular disease.
Controlling your blood sugar also reduces hunger and cravings.
Semaglutide slows how fast your stomach digests food and pushes it into your intestines. If food stays in your stomach longer, you feel full longer. You eat less and consume fewer excess calories.
Your stomach and intestines are part of your gut-brain axis. Chemicals released from your gut impact your brain. Likewise, chemicals released from your brain impact hunger and how your body uses food to fuel itself.
Semaglutide acts in your brain and gut to control your hunger and cravings and help you feel satisfied with the food you eat.
GLP-1, along with other hormones such as leptin (fullness hormone), tells your brain you are full.
The hypothalamus is a part of the brain that controls hunger and regulates energy use. Semaglutide boosts GLP-1 in your body, telling your brain you are not hungry. You think less about food and find it much easier to control cravings.
Researchers are investigating how GLP-1 affects other key areas of the brain that influence food intake. Parts of the brain that control reward, emotion, memory, attention, and cognitive decision-making also control hunger and appetite. Semaglutide may help people who describe themselves as emotional eaters or people who eat more when they are bored control their food intake.
How Does Semaglutide Work?
Semaglutide Suppresses Your Appetite and Reduces Cravings
Semaglutide is a glucagon-like peptide 1 (GLP-1) agonist. GLP-1 is a hormone that binds to brain receptors that control hunger and appetite. Semaglutide causes weight loss by suppressing appetite and reducing hunger. It decreases appetite by delaying stomach emptying and slowing intestinal motility, so you feel full longer.
Semaglutide stabilizes your blood sugar
Semaglutide stimulates insulin secretion from the pancreas and reduces glucagon release, which lowers blood glucose. Insulin ushers glucose from the blood into your body cells, where it can be used for energy.
Semaglutide induces weight loss
Four primary clinical trials were conducted to test semaglutide’s safety and effectiveness. These trials evaluated the drug’s effects in people who were overweight or obese, with or without diabetes, and combined them with mild or moderate behavioral interventions such as counseling about diet and exercise or meal replacements. In all cases, groups that took semaglutide lost more weight than groups that took a placebo.
In the largest trial, the group that received semaglutide lost 15% more weight at 68 weeks when compared to a placebo. This was equivalent to an average weight loss of 35 pounds.
Included with the Plan
Free Doctor Consult
No Doctors Office
No Hidden Fees
- Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. Jama. 2021;325(14):1414-1425
- Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, O’Neil PM, Rubino DM, Skovgaard D, Wallenstein SOR, Garvey WT, Investigators S. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021;325(14):1403-1413.
- Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564.
- Davies M, Færch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA, Lingvay I. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet. 2021;397(10278):971-984
- Kadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, Tobe K, Yamauchi T, Lim S. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial. Lancet Diabetes Endocrinol. 2022;10(3):193-206.